The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 17, 2025
Filed:
Apr. 09, 2020
Applicant:
Scripps Korea Antibody Institute, Gangwon-do, KR;
Inventors:
Dae Hee Kim, Seoul, KR;
Eung-Suk Lee, Gwangwon-do, KR;
Min Jung Kim, Gangwon-do, KR;
Nara Tae, Gangwon-do, KR;
Jong Rip Choi, Gangwon-do, KR;
Assignee:
SCRIPPS KOREA ANTIBODY INSTITUTE, Gangwon-Do, KR;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/395 (2006.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); C12N 5/10 (2006.01); C12N 15/10 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2827 (2013.01); A61K 39/3955 (2013.01); A61K 47/6849 (2017.08); A61P 35/00 (2018.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); C07K 2317/31 (2013.01); C07K 2317/33 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01);
Abstract
Disclosed are an antibody to programmed death-ligand 1 (PD-L1) or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector including the nucleic acid, a cell transfected with the vector, a method of producing the antibody or the antigen-binding fragment thereof, a composition for preventing or treating cancer including the same, and a composition for combination therapy for preventing or treating cancer including the same.